
Effervescent Tablet Market Report and Forecast 2025-2034
Description
The global effervescent tablet market size was valued at USD 25.33 Billion in 2024, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 8.70% during the forecast period of 2025-2034 to achieve a value of USD 58.34 Billion by 2034.
Effervescent Tablet: Introduction
Effervescent tablets are the type of tablets that dissolve easily in water or other liquids while releasing carbon dioxide. The tablet breaks down easily hence it dissolves into a frothy or fizzy solution. With the use of these tablets, various other drugs can be consumed by consumers. Effervescent tablets come with various advantages. The tablets quickly deliver the dosage to the body as the medications are supplied in the form of a readily absorbed solution.
Effervescent tablets are manufactured by compressing powdered ingredients into a compact form, which is then packaged either in a blister pack or a hermetically sealed package that includes a desiccant in the cap. To use them, simply drop the tablets into water to create a solution. Alternatively, the powdered ingredients may be sold as effervescent powders or granulated and sold as effervescent granules.
Global Effervescent Tablet Market Analysis
The market is witnessing an increase in the number of research and development activities, which further aids the growth of the market. Major key players in the market are continuously working on developing novel drugs to enhance the health and lifestyle of patients. The innovation in the formulation of these tablets is also responsible for increasing global effervescent tablets market share. For example, effervescent products that quickly transform into beverages are beneficial for the environment as they decrease the use of plastics. The use of various formulations of materials also enhances the process of administration, further increasing the global effervescent tablets market growth.
The heavy investments in the development of innovative technologies and novel effervescent products are also expected to majorly boost market growth by providing market opportunities for manufacturers to develop new and innovative effervescent products.
Global Effervescent Tablet Market Segmentations
The EMR’s report titled “Effervescent Tablet Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
The growth of the market can be significantly attributed to the increasing prevalence of chronic diseases globally. These tablets are easy to use and only require a drop of water to make a solution. The increased demand for effervescent tablets is driven by various aspects, such as the pleasant taste, distribution more evenly, increased liquid intake, easy alternative to regular tablets, and simple and easy-to-measure. These tablets are even safe to consume comparatively. The easy availability of these tablets over various distribution channels is a major factor driving the global effervescent tablets market growth. For example, the availability of these tablets even as glucose tablets provides a quick energy boost. This acts as a major relief to chronic patients and thus boosts the market growth.
The increasing health awareness among people and rising disposable income have also shifted their focus towards healthy products, such as probiotics, vitamins, dietary supplements, and minerals, which further drives the global effervescent tablets market growth.
The widespread availability of effervescent products, such as dietary supplements to prevent diseases, and nutritional deficiencies and improve consumers' overall health and lifestyle, is a major factor fuelling the market growth. The production of new products and launches in the market is expected to drive the market growth further.
Geographically, North America is expected to dominate the market due to the presence of major key players. The increased healthcare expenditure is also expected to boost the growth of the regional market. The market is also driven by the increasing number of research and development activities in the region.
Global Effervescent Tablet Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Effervescent Tablet: Introduction
Effervescent tablets are the type of tablets that dissolve easily in water or other liquids while releasing carbon dioxide. The tablet breaks down easily hence it dissolves into a frothy or fizzy solution. With the use of these tablets, various other drugs can be consumed by consumers. Effervescent tablets come with various advantages. The tablets quickly deliver the dosage to the body as the medications are supplied in the form of a readily absorbed solution.
Effervescent tablets are manufactured by compressing powdered ingredients into a compact form, which is then packaged either in a blister pack or a hermetically sealed package that includes a desiccant in the cap. To use them, simply drop the tablets into water to create a solution. Alternatively, the powdered ingredients may be sold as effervescent powders or granulated and sold as effervescent granules.
Global Effervescent Tablet Market Analysis
The market is witnessing an increase in the number of research and development activities, which further aids the growth of the market. Major key players in the market are continuously working on developing novel drugs to enhance the health and lifestyle of patients. The innovation in the formulation of these tablets is also responsible for increasing global effervescent tablets market share. For example, effervescent products that quickly transform into beverages are beneficial for the environment as they decrease the use of plastics. The use of various formulations of materials also enhances the process of administration, further increasing the global effervescent tablets market growth.
The heavy investments in the development of innovative technologies and novel effervescent products are also expected to majorly boost market growth by providing market opportunities for manufacturers to develop new and innovative effervescent products.
Global Effervescent Tablet Market Segmentations
The EMR’s report titled “Effervescent Tablet Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Medication
- Supplement
- Prescription Based
- Over The Counter (OTC)
- Pharmaceutical
- Dietary Supplements
- Dental Products
- Others
- Hospitals
- Homecare
- Specialty Clinics
- Others
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The growth of the market can be significantly attributed to the increasing prevalence of chronic diseases globally. These tablets are easy to use and only require a drop of water to make a solution. The increased demand for effervescent tablets is driven by various aspects, such as the pleasant taste, distribution more evenly, increased liquid intake, easy alternative to regular tablets, and simple and easy-to-measure. These tablets are even safe to consume comparatively. The easy availability of these tablets over various distribution channels is a major factor driving the global effervescent tablets market growth. For example, the availability of these tablets even as glucose tablets provides a quick energy boost. This acts as a major relief to chronic patients and thus boosts the market growth.
The increasing health awareness among people and rising disposable income have also shifted their focus towards healthy products, such as probiotics, vitamins, dietary supplements, and minerals, which further drives the global effervescent tablets market growth.
The widespread availability of effervescent products, such as dietary supplements to prevent diseases, and nutritional deficiencies and improve consumers' overall health and lifestyle, is a major factor fuelling the market growth. The production of new products and launches in the market is expected to drive the market growth further.
Geographically, North America is expected to dominate the market due to the presence of major key players. The increased healthcare expenditure is also expected to boost the growth of the regional market. The market is also driven by the increasing number of research and development activities in the region.
Global Effervescent Tablet Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Pfizer Inc.
- GSK plc
- Novartis AG
- Bayer AG
- Perrigo Company plc
- Reckitt Benckiser Group PLC
- Bristol-Myers Squibb Company
- CHIESI SAS
- Hermes Pharma
- S. G. Biopharm Pvt. Ltd
- Bliss GVS Pharma Limited
- Amerilab Technologies Inc.
- HERMES ARZNEIMITTEL
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Effervescent Tablet Market Overview
- 3.1 Global Effervescent Tablet Market Historical Value (2018-2024)
- 3.2 Global Effervescent Tablet Market Forecast Value (2025-2034)
- 4 Global Effervescent Tablet Market Landscape
- 4.1 Global Effervescent Tablet Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Effervescent Tablet Product Landscape
- 4.2.1 Analysis by Product
- 4.2.2 Analysis by Type
- 4.2.3 Analysis by Application
- 5 Global Effervescent Tablet Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Effervescent Tablet Market Segmentation
- 6.1 Global Effervescent Tablet Market by Product
- 6.1.1 Market Overview
- 6.1.2 Medication
- 6.1.3 Supplement
- 6.2 Global Effervescent Tablet Market by Type
- 6.2.1 Market Overview
- 6.2.2 Prescription Based
- 6.2.3 Over The Counter (OTC)
- 6.3 Global Effervescent Tablet Market by Application
- 6.3.1 Market Overview
- 6.3.2 Pharmaceutical
- 6.3.3 Dietary Supplements
- 6.3.4 Dental Products
- 6.3.5 Others
- 6.4 Global Effervescent Tablet Market by End User
- 6.4.1 Market Overview
- 6.4.2 Hospitals
- 6.4.3 Homecare
- 6.4.4 Specialty Clinics
- 6.4.5 Others
- 6.5 Global Effervescent Tablet Market by Distribution Channel
- 6.5.1 Market Overview
- 6.5.2 Hospital Pharmacy
- 6.5.3 Online Pharmacy
- 6.5.4 Retail Pharmacy
- 6.5.5 Others
- 6.6 Global Effervescent Tablet Market by Region
- 6.6.1 Market Overview
- 6.6.2 North America
- 6.6.3 Europe
- 6.6.4 Asia Pacific
- 6.6.5 Latin America
- 6.6.6 Middle East and Africa
- 7 North America Effervescent Tablet Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Effervescent Tablet Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Effervescent Tablet Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Effervescent Tablet Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Effervescent Tablet Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Pfizer Inc.
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 GSK plc
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Novartis AG
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Bayer AG
- 17.4.1 Financial Analysis
- 17.4.2 Financial Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Perrigo Company plc
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Reckitt Benckiser Group PLC
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Bristol-Myers Squibb Company
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 CHIESI SAS
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Hermes Pharma
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 S. G. Biopharm Pvt. Ltd
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 Bliss GVS Pharma Limited
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 Amerilab Technologies Inc.
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 HERMES ARZNEIMITTEL
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 18 Global Effervescent Tablet Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.